The Fort Worth Press - US abortion ruling threatens access to arthritis drug

USD -
AED 3.672985
AFN 68.564771
ALL 93.747911
AMD 390.284429
ANG 1.810594
AOA 913.509585
ARS 1003.974897
AUD 1.540035
AWG 1.8025
AZN 1.695095
BAM 1.867656
BBD 2.028371
BDT 120.054049
BGN 1.8769
BHD 0.376987
BIF 2967.603314
BMD 1
BND 1.350013
BOB 6.941467
BRL 5.816273
BSD 1.004588
BTN 84.879318
BWP 13.715061
BYN 3.287735
BYR 19600
BZD 2.025029
CAD 1.399205
CDF 2869.999779
CHF 0.88787
CLF 0.035289
CLP 973.739762
CNY 7.248704
CNH 7.261055
COP 4389.25
CRC 510.697626
CUC 1
CUP 26.5
CVE 105.296581
CZK 24.37597
DJF 178.896958
DKK 7.15976
DOP 60.533139
DZD 133.646288
EGP 49.731703
ERN 15
ETB 125.19309
EUR 0.95985
FJD 2.27535
FKP 0.789317
GBP 0.79789
GEL 2.725037
GGP 0.789317
GHS 15.9733
GIP 0.789317
GMD 71.00031
GNF 8659.405931
GTQ 7.755077
GYD 210.182537
HKD 7.783795
HNL 25.38723
HRK 7.133259
HTG 131.897725
HUF 394.705022
IDR 15911.4
ILS 3.721435
IMP 0.789317
INR 84.47995
IQD 1316.106114
IRR 42104.999996
ISK 140.210173
JEP 0.789317
JMD 159.547343
JOD 0.709102
JPY 154.53898
KES 129.549834
KGS 86.499929
KHR 4051.853797
KMF 469.649893
KPW 899.999621
KRW 1405.050428
KWD 0.30774
KYD 0.837201
KZT 498.204702
LAK 22005.452662
LBP 89966.529634
LKR 292.295131
LRD 181.336364
LSL 18.178163
LTL 2.95274
LVL 0.60489
LYD 4.907395
MAD 10.047317
MDL 18.293632
MGA 4704.107261
MKD 58.76173
MMK 3247.960992
MNT 3397.999946
MOP 8.054107
MRU 39.953781
MUR 46.849963
MVR 15.450407
MWK 1742.028515
MXN 20.47025
MYR 4.467505
MZN 63.913532
NAD 18.17825
NGN 1691.080248
NIO 36.77015
NOK 11.128895
NPR 135.806643
NZD 1.71322
OMR 0.385062
PAB 1.004588
PEN 3.816004
PGK 4.044176
PHP 58.934986
PKR 279.238615
PLN 4.16856
PYG 7884.8734
QAR 3.662677
RON 4.775598
RSD 112.291014
RUB 103.632259
RWF 1380.387139
SAR 3.754515
SBD 8.36952
SCR 13.619873
SDG 601.500789
SEK 11.12161
SGD 1.34755
SHP 0.789317
SLE 22.584986
SLL 20969.504736
SOS 574.129781
SRD 35.404949
STD 20697.981008
SVC 8.790275
SYP 2512.529858
SZL 18.186159
THB 34.624501
TJS 10.699307
TMT 3.51
TND 3.178235
TOP 2.342101
TRY 34.561285
TTD 6.819267
TWD 32.597018
TZS 2655.858977
UAH 41.476647
UGX 3711.856071
UYU 42.810419
UZS 12855.000234
VES 46.269553
VND 25427.5
VUV 118.722009
WST 2.791591
XAF 626.409275
XAG 0.03196
XAU 0.000371
XCD 2.70255
XDR 0.766351
XOF 626.39432
XPF 113.885189
YER 249.902147
ZAR 18.098971
ZMK 9001.200433
ZMW 27.702577
ZWL 321.999592
  • RBGPF

    59.6900

    59.69

    +100%

  • RYCEF

    0.1800

    6.79

    +2.65%

  • CMSC

    0.1200

    24.64

    +0.49%

  • CMSD

    0.1850

    24.445

    +0.76%

  • RELX

    0.6500

    45.76

    +1.42%

  • SCS

    -0.0300

    13.04

    -0.23%

  • GSK

    0.3500

    33.7

    +1.04%

  • RIO

    0.1800

    62.57

    +0.29%

  • NGG

    -0.1700

    63.1

    -0.27%

  • AZN

    1.0600

    64.26

    +1.65%

  • JRI

    0.0000

    13.23

    0%

  • VOD

    -0.1000

    8.84

    -1.13%

  • BCE

    -0.3200

    26.68

    -1.2%

  • BCC

    2.9500

    140.36

    +2.1%

  • BTI

    -0.1000

    36.98

    -0.27%

  • BP

    0.4400

    29.52

    +1.49%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: © POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

T.Harrison--TFWP